{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T19:07:46Z","timestamp":1775070466757,"version":"3.50.1"},"reference-count":65,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1016\/j.jaad.2010.08.040","type":"journal-article","created":{"date-parts":[[2011,7,24]],"date-time":"2011-07-24T17:44:45Z","timestamp":1311529485000},"page":"1213.e1-1213.e15","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Cutaneous manifestations of category A\u00a0bioweapons"],"prefix":"10.1016","volume":"65","author":[{"given":"Lisa L.","family":"Aquino","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jashin J.","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2010.08.040_bib1","doi-asserted-by":"crossref","first-page":"933","DOI":"10.3201\/eid0706.010604","article-title":"Bioterrorism-related inhalational anthrax","volume":"7","author":"Jernigan","year":"2001","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.jaad.2010.08.040_bib2","first-page":"A10","article-title":"Modest gains against ever-present bioterrorism threat","author":"Hsu","year":"2008","journal-title":"Washington Post"},{"key":"10.1016\/j.jaad.2010.08.040_bib3","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.det.2004.03.008","article-title":"The history of biological warfare and bioterrorism","volume":"22","author":"Jacobs","year":"2004","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.jaad.2010.08.040_bib4","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1001\/archderm.139.12.1657","article-title":"Bioterrorism preparedness in the dermatology community","volume":"139","author":"Carroll","year":"2003","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2010.08.040_bib5","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.dmr.2004.06.011","article-title":"Physician preparedness for bioterrorism recognition and response: a Utah-based needs assessment","volume":"2","author":"Alder","year":"2004","journal-title":"Disaster Manag Response"},{"key":"10.1016\/j.jaad.2010.08.040_bib6","unstructured":"American Academy of Dermatology. Disaster Preparedness. Available at: http:\/\/www.aad.org\/members\/disaster\/bioterrorism\/index.html. Accessed February 13, 2011."},{"key":"10.1016\/j.jaad.2010.08.040_bib7","unstructured":"Robinson JP, Cosivi O, Davey BJ, Hay AWM, Kenyon IR, Krutzsch\u00a0W, et al. Public health response to biological and\u00a0chemical weapons: WHO guidance. 2004. Available at: http:\/\/www.who.int\/csr\/delibepidemics\/biochemguide\/en\/index.html. Accessed August 12, 2009."},{"key":"10.1016\/j.jaad.2010.08.040_bib8","series-title":"Health aspects of chemical and biological weapons","year":"1970"},{"key":"10.1016\/j.jaad.2010.08.040_bib9","unstructured":"Emergency Preparedness and Response. Bioterrorism. Available at: http:\/\/www.bt.cdc.gov\/bioterrorism\/. Accessed February 13,\u00a02011."},{"key":"10.1016\/j.jaad.2010.08.040_bib10","series-title":"The bioterrorism sourcebook","author":"Grey","year":"2006"},{"key":"10.1016\/j.jaad.2010.08.040_bib11","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1001\/archderm.135.3.311","article-title":"Cutaneous manifestations of biological warfare and related threat agents","volume":"135","author":"McGovern","year":"1999","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2010.08.040_bib12","series-title":"Biological weapons defense: infectious diseases and counterbioterrorism","author":"LeClaire","year":"2005"},{"key":"10.1016\/j.jaad.2010.08.040_bib13","unstructured":"Arizona Department of Health Services. Epsilon Toxin of Clostridium Perfrigens. Available at: http:\/\/www.azdhs.gov\/phs\/edc\/edrp\/pdf\/epsilontoxinset.pdf. Accessed February 13, 2011."},{"key":"10.1016\/j.jaad.2010.08.040_bib14","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/0002-9343(92)90173-9","article-title":"Epidemiological features and clinical presentation of acute Q fever in hospitalized patients: 323 French cases","volume":"93","author":"Tissot Dupont","year":"1992","journal-title":"Am J Med"},{"key":"10.1016\/j.jaad.2010.08.040_bib15","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1097\/00006454-200004000-00021","article-title":"Rash and petechiae as presenting signs of Q fever","volume":"19","author":"Van Hensbroek","year":"2000","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jaad.2010.08.040_bib16","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1177\/120347540500900302","article-title":"Rickettsial infections around the world, part 2: rickettsialpox, the typhus group, and bioterrorism","volume":"19","author":"Wu","year":"2005","journal-title":"J Cutan Med Surg"},{"key":"10.1016\/j.jaad.2010.08.040_bib17","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.idc.2006.03.003","article-title":"Category C potential bioterrorism agents and emerging pathogens","volume":"20","author":"Mushtaq","year":"2006","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.jaad.2010.08.040_bib18","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0733-8627(01)00003-7","article-title":"Threats in bioterrorism II: CDC category B and C agents","volume":"20","author":"Moran","year":"2002","journal-title":"Emerg Med Clin North Am"},{"key":"10.1016\/j.jaad.2010.08.040_bib19","doi-asserted-by":"crossref","first-page":"3669","DOI":"10.1681\/ASN.2005050561","article-title":"Hantavirus infection","volume":"16","author":"Muranyi","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jaad.2010.08.040_bib20","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.det.2004.03.004","article-title":"Other biologic toxin bioweapons: ricin, staphylococcal enterotoxin B, and trichothecene mycotoxins","volume":"22","author":"Hengold","year":"2004","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.jaad.2010.08.040_bib21","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1001\/jama.287.4.425","article-title":"Mycotoxins","volume":"287","author":"Etzel","year":"2002","journal-title":"Jama"},{"key":"10.1016\/j.jaad.2010.08.040_bib22","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/S0738-081X(02)00250-X","article-title":"The story of anthrax from antiquity to the present: a biological weapon of nature and humans","volume":"20","author":"Witkowski","year":"2002","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.jaad.2010.08.040_bib23","unstructured":"Infectious Disease Society of America. Biodefense Information and Resources. Available at: http:\/\/www.idsociety.org\/bt\/toc.htm. Accessed February 13, 2011."},{"key":"10.1016\/j.jaad.2010.08.040_bib24","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1126\/science.7973702","article-title":"The Sverdlovsk anthrax outbreak of 1979","volume":"255","author":"Meselson","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.jaad.2010.08.040_bib25","unstructured":"Norton S. Bioterrorism and the dermatologist: a newsmaker interview with Scott Norton. 2002. Available at: http:\/\/www.medscape.com\/viewarticle\/439902. Accessed August 12, 2009."},{"key":"10.1016\/j.jaad.2010.08.040_bib26","unstructured":"American Academy of Dermatology Ad Hoc Task Force on Bioterrorism. Cutaneous Anthrax Management Algorithm. Available at: http:\/\/www.aad.org\/members\/disaster\/bioterrorism\/bio_anthrax_cutaneous.html. Accessed February 13, 2011."},{"key":"10.1016\/j.jaad.2010.08.040_bib27","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1001\/jama.281.18.1735","article-title":"Anthrax as a biological weapon","volume":"281","author":"Inglesby","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.jaad.2010.08.040_bib28","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1542\/peds.2006-1722","article-title":"The use of systemic fluoroquinolones","volume":"118","year":"2006","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaad.2010.08.040_bib29","unstructured":"Food and Drug Administration. Postmarket Drug Safety Information for Patients and Providers. Information for Health Care Professionals. May 29, 2010. Available at: http:\/\/www.fda.gov\/Drugs\/DrugSafety\/PostmarketDrugSafetyInformationforPatientsandProviders\/ucm126085.htm. Accessed February 13, 2011."},{"key":"10.1016\/j.jaad.2010.08.040_bib30","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0733-8627(02)00005-6","article-title":"Threats in bioterrorism I: CDC category A\u00a0agents","volume":"20","author":"Darling","year":"2002","journal-title":"Emerg Med Clin North Am"},{"key":"10.1016\/j.jaad.2010.08.040_bib31","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1001\/jama.283.17.2281","article-title":"Plague as a biological weapon: medical and public health management","volume":"283","author":"Inglesby","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.jaad.2010.08.040_bib32","unstructured":"Plague Fact Sheet. Center for Biosecurity of UPMC. Available at:\u00a0http:\/\/www.upmc-biosecurity.org\/website\/focus\/agents_diseases\/fact_sheets\/plague.html. Accessed February 13, 2011."},{"key":"10.1016\/j.jaad.2010.08.040_bib33","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.emc.2008.01.006","article-title":"Infectious agents of bioterrorism: a review for emergency physicians","volume":"26","author":"Kman","year":"2008","journal-title":"Emerg Med Clin North Am"},{"key":"10.1016\/j.jaad.2010.08.040_bib34","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1097\/00000441-200206000-00004","article-title":"Viral agents as biological weapons and agents of bioterrorism","volume":"323","author":"Bronze","year":"2002","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.jaad.2010.08.040_bib35","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1097\/01.all.0000136758.66442.28","article-title":"Smallpox, vaccination and adverse reactions to vaccine","volume":"4","author":"Wollenberg","year":"2004","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.jaad.2010.08.040_bib36","unstructured":"World Health Organization. Smallpox. Available at: http:\/\/www.who.int\/csr\/disease\/smallpox\/en\/. Accessed February 13, 2011."},{"key":"10.1016\/j.jaad.2010.08.040_bib37","series-title":"Smallpox","author":"Rao","year":"1972"},{"key":"10.1016\/j.jaad.2010.08.040_bib38","doi-asserted-by":"crossref","first-page":"S75","DOI":"10.1097\/01.CCM.0000151070.56915.22","article-title":"Bioterrorism: preparing for the impossible or improbable","volume":"33","author":"Karwa","year":"2005","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jaad.2010.08.040_bib39","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0140-6736(06)68143-9","article-title":"Smallpox","volume":"267","author":"Moore","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.jaad.2010.08.040_bib40","series-title":"Textbook of human virology","first-page":"929","article-title":"Poxviruses","author":"Baxby","year":"1984"},{"key":"10.1016\/j.jaad.2010.08.040_bib41","doi-asserted-by":"crossref","first-page":"2763","DOI":"10.1001\/jama.285.21.2763","article-title":"Tularemia as a biological weapon: medical and public health management","volume":"285","author":"Dennis","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.jaad.2010.08.040_bib42","first-page":"55","article-title":"Tularemia","volume":"12","author":"Jacobs","year":"1997","journal-title":"Adv Pediatr Infect Dis"},{"key":"10.1016\/j.jaad.2010.08.040_bib43","first-page":"314","article-title":"Tularemia in North Carolina, 1965-1990","volume":"56","author":"Langley","year":"1995","journal-title":"N C Med J"},{"key":"10.1016\/j.jaad.2010.08.040_bib44","first-page":"1","article-title":"Biological and chemical terrorism: strategic plan for preparedness and response: recommendations of the CDC Strategic Planning Workgroup","volume":"49","year":"2000","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.jaad.2010.08.040_bib45","series-title":"Medical aspects of chemical and biological warfare","first-page":"503","article-title":"Tularemia","author":"Evans","year":"1997"},{"key":"10.1016\/j.jaad.2010.08.040_bib46","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.idc.2008.03.004","article-title":"Tularemia","volume":"22","author":"Nigrovic","year":"2008","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.jaad.2010.08.040_bib47","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1001\/jama.1925.02660430001001","article-title":"Tularemia","volume":"84","author":"Francis","year":"1925","journal-title":"Jama"},{"key":"10.1016\/j.jaad.2010.08.040_bib48","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1007\/s00018-006-6308-z","article-title":"Bioterrorism: management of major biologic agents","volume":"63","author":"Bossi","year":"2006","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.jaad.2010.08.040_bib49","series-title":"Biohazard","author":"Alibek","year":"1999"},{"key":"10.1016\/j.jaad.2010.08.040_bib50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1196\/annals.1409.009","article-title":"Tularemia: history, epidemiology, pathogen physiology, and clinical manifestations","volume":"1105","author":"Sjostedt","year":"2007","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.jaad.2010.08.040_bib51","first-page":"161","article-title":"Tularemia","volume":"Vol 2","author":"Bell","year":"1980"},{"key":"10.1016\/j.jaad.2010.08.040_bib52","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1001\/jama.287.18.2391","article-title":"Hemorrhagic fever viruses and biologic weapons: medical and public health management","volume":"287","author":"Borio","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.jaad.2010.08.040_bib53","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.ccc.2005.06.007","article-title":"Hemorrhagic fever viruses","volume":"21","author":"Piggot","year":"2005","journal-title":"Crit Care Clin"},{"key":"10.1016\/j.jaad.2010.08.040_bib54","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.det.2004.03.003","article-title":"Other viral bioweapons: Ebola and Marburg hemorrhagic fever","volume":"22","author":"Salvaggio","year":"2004","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.jaad.2010.08.040_bib55","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0166-3542(02)00202-4","article-title":"Arenaviruses other than Lassa fever virus","volume":"57","author":"Charrel","year":"2003","journal-title":"Antiviral Res"},{"key":"10.1016\/j.jaad.2010.08.040_bib56","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/0-387-33026-7_4","article-title":"Viral hemorrhagic fevers caused by Lassa, Ebola, and Marburg viruses","volume":"582","author":"Curtis","year":"2006","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.jaad.2010.08.040_bib57","unstructured":"World Health Organization. Acute hemorrhagic fever syndrome. Available at: http:\/\/www.who.int\/csr\/resources\/publications\/surveillance\/whocdscsrisr992syn.pdf. Accessed August 12, 2009."},{"key":"10.1016\/j.jaad.2010.08.040_bib58","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1093\/infdis\/167.5.1239","article-title":"Postexposure prophylaxis against experimental inhalation anthrax","volume":"167","author":"Friedlander","year":"1993","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jaad.2010.08.040_bib59","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1001\/jama.1997.03550050061035","article-title":"Clinical recognition and management of patients exposed to biological warfare agents","volume":"278","author":"Franz","year":"1997","journal-title":"JAMA"},{"key":"10.1016\/j.jaad.2010.08.040_bib60","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1093\/infdis\/166.5.1184","article-title":"Serum concentrations of penicillin, doxycycline, and ciprofloxacin during prolonged therapy in rhesus monkeys","volume":"166","author":"Kelly","year":"1992","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jaad.2010.08.040_bib61","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1001\/jama.281.22.2127","article-title":"Smallpox as a biological weapon: medical and public health management","volume":"281","author":"Henderson","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.jaad.2010.08.040_bib62","first-page":"39","article-title":"Treatment of tularemia, including pulmonary tularemia, with gentamicin","volume":"121","author":"Mason","year":"1980","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.jaad.2010.08.040_bib63","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1093\/jac\/41.4.461","article-title":"The efficacy of ciprofloxacin and doxycycline against experimental tularemia","volume":"41","author":"Russell","year":"1998","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jaad.2010.08.040_bib64","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1086\/520458","article-title":"Treatment of tularemia with fluoroquinolones: two cases and review","volume":"29","author":"Limaye","year":"1999","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaad.2010.08.040_bib65","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJM198601023140104","article-title":"Lassa fever: effective therapy with ribavirin","volume":"314","author":"McCormick","year":"1986","journal-title":"N Engl J Med"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962210021444?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962210021444?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:20:58Z","timestamp":1759270858000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962210021444"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":65,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["S0190962210021444"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2010.08.040","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cutaneous manifestations of category A\u00a0bioweapons","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2010.08.040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}